Anna Genell

780 total citations
11 papers, 536 citations indexed

About

Anna Genell is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Anna Genell has authored 11 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Anna Genell's work include Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (5 papers) and Protein Degradation and Inhibitors (4 papers). Anna Genell is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Peptidase Inhibition and Analysis (5 papers) and Protein Degradation and Inhibitors (4 papers). Anna Genell collaborates with scholars based in Sweden, United States and Norway. Anna Genell's co-authors include Gunnar Steineck, Szilárd Nemes, Junmei Miao Jonasson, Paul W. Dickman, Cecilie Blimark, Ingemar Turesson, Kristina Carlson, Bo Björkstrand, Hareth Nahi and Olle Linder and has published in prestigious journals such as Blood, BMC Medical Research Methodology and Haematologica.

In The Last Decade

Anna Genell

11 papers receiving 517 citations

Peers

Anna Genell

HEMAT

ONCOL

EPIDE

PHEOH

Wan‐Ling Hsu Japan

Roger D. Klein United States

Charles Warne Australia

W. Benjamin Nowell United States

Ikhlaaq Ahmed United Kingdom

Eline van Overbeeke Belgium

Norah L. Crossnohere United States

Aris Angelis United Kingdom

Ariel Béresniak France

Ateesha F. Mohamed United States

Wan‐Ling Hsu Japan

Anna Genell

104 ×0.7

HEMAT

96 ×0.9

ONCOL

88 ×0.9

74 ×1.3

EPIDE

111 ×2.0

PHEOH

Citations per year, relative to Anna Genell Anna Genell (= 1×) peers Wan‐Ling Hsu

Countries citing papers authored by Anna Genell

Since Specialization

Citations

This map shows the geographic impact of Anna Genell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Genell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Genell more than expected).

Fields of papers citing papers by Anna Genell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Genell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Genell. The network helps show where Anna Genell may publish in the future.

Co-authorship network of co-authors of Anna Genell

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Genell. A scholar is included among the top collaborators of Anna Genell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Genell. Anna Genell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Genell, Anna, Katrin Palk, Valdas Pečeliūnas, et al.. (2023). Upfront Autologous Stem Cell Transplantation in Myeloma Patients >65 Years: A Population-Based Study from the Nordic Myeloma Study Group. Blood. 142(Supplement 1). 4729–4729. 1 indexed citations

Turesson, Ingemar, Anna Genell, Tobias Wirenfeldt Klausen, et al.. (2022). Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden. Haematologica. 108(6). 1640–1651. 8 indexed citations

Wålinder, Göran, Anna Genell, Gunnar Juliusson, et al.. (2022). Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study. Cancer Reports. 5(11). e1614–e1614. 1 indexed citations

Blimark, Cecilie, et al.. (2021). P-167: Real-world elderly myeloma patients: improved survival despite more adverse risk factors than younger patients and RCT populations. A study on behalf of the Nordic Myeloma Study Group. Clinical Lymphoma Myeloma & Leukemia. 21. S127–S128. 1 indexed citations

Hellström, Andreas, K. Gunnarsdóttir, Anna Genell, et al.. (2021). Exploring the meaning, role and experiences of a patient-led social innovation for people affected by cancer: a new collaborative care model complementing traditional cancer rehabilitation in Sweden. BMJ Open Quality. 10(4). e001400–e001400. 1 indexed citations

Gunnarsdóttir, K., Anna Genell, Daniel McLinden, et al.. (2018). Evaluating the implementation and use of the regional cancer plan in Western Sweden through concept mapping. International Journal for Quality in Health Care. 31(7). 44–52. 4 indexed citations

Blimark, Cecilie, Ingemar Turesson, Anna Genell, et al.. (2017). Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry. Haematologica. 103(3). 506–513. 97 indexed citations

Nahi, Hareth, Anna Genell, Göran Wålinder, et al.. (2017). Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population‐based data from the Swedish Myeloma Register. European Journal Of Haematology. 99(3). 216–222. 38 indexed citations

Genell, Anna, Szilárd Nemes, Gunnar Steineck, & Paul W. Dickman. (2010). Model selection in Medical Research: A simulation study comparing Bayesian Model Averaging and Stepwise Regression. BMC Medical Research Methodology. 10(1). 108–108. 69 indexed citations

10.

Nemes, Szilárd, Junmei Miao Jonasson, Anna Genell, & Gunnar Steineck. (2009). Bias in odds ratios by logistic regression modelling and sample size. BMC Medical Research Methodology. 9(1). 56–56. 312 indexed citations

11.

Genell, Anna, et al.. (2009). Usefulness of current risk groups in the treatment of surgically staged endometrial carcinomas; a population-based study from Western Sweden.. PubMed. 29(5). 1585–90. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact